A transaction sharpens directors' duties, because approving a deal commits the company and exposes the board to claims that it failed to act with care, on an informed basis, or in the company's and stakeholders' interests. For a director, the risk is personal as well as corporate, particularly where the deal later sours or the company approaches insolvency. This report explains how deal risk bears on directors' duties in your chosen jurisdiction and industry, the standards of care and process expected, conflicts and disclosure obligations, warning indicators of a flawed board process, and hedged impact ranges from published cases. Framed as research rather than legal advice, it shows how boards evidence sound decision-making and when to engage independent counsel, financial advisers and governance specialists to protect both the company and individual directors.
Reference material for informed readers, not advice.
